OSD’s Greatest Hits: 2024 Edition

In this month’s episode of To the Point, Jackie Garlich, OD, FAAO, and Cecelia Koetting, OD, FAAO, Dipl ABO, talk about the most exciting, important, and novel ocular surface disease (OSD) news to come out of the past year, including FDA approvals, product launches, new clinical data, and more. They also discuss what developments to watch out for in the OSD space this coming year.